Global Tuberculosis (TB) Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Tuberculosis (TB) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Tuberculosis (TB) Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Active TB accounting for % of the Tuberculosis (TB) Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Isoniazid segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Tuberculosis (TB) Treatment include Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd, Macleods Pharmaceutical Ltd, Dong-A ST Co., Ltd, and Lupin Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tuberculosis (TB) Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide
Market segment by Application, can be divided into
Active TB
Latent TB
Market segment by players, this report covers
Johnson & Johnson
Otsuka Pharmaceutical Co., Ltd
Macleods Pharmaceutical Ltd
Dong-A ST Co., Ltd
Lupin Ltd
Janssen Products, LP
Mylan
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Tuberculosis (TB) Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Tuberculosis (TB) Treatment, with revenue, gross margin and global market share of Tuberculosis (TB) Treatment from 2019 to 2022.
Chapter 3, the Tuberculosis (TB) Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Tuberculosis (TB) Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Tuberculosis (TB) Treatment research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Tuberculosis (TB) Treatment
1.2 Classification of Tuberculosis (TB) Treatment by Type
1.2.1 Overview: Global Tuberculosis (TB) Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Tuberculosis (TB) Treatment Revenue Market Share by Type in 2021
1.2.3 Isoniazid
1.2.4 Rifampin (Rifadin, Rimactane)
1.2.5 Ethambutol (Myambutol)
1.2.6 Pyrazinamide
1.3 Global Tuberculosis (TB) Treatment Market by Application
1.3.1 Overview: Global Tuberculosis (TB) Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Active TB
1.3.3 Latent TB
1.4 Global Tuberculosis (TB) Treatment Market Size & Forecast
1.5 Global Tuberculosis (TB) Treatment Market Size and Forecast by Region
1.5.1 Global Tuberculosis (TB) Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Tuberculosis (TB) Treatment Market Size by Region, (2017-2022)
1.5.3 North America Tuberculosis (TB) Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Tuberculosis (TB) Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Tuberculosis (TB) Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Tuberculosis (TB) Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Tuberculosis (TB) Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Tuberculosis (TB) Treatment Market Drivers
1.6.2 Tuberculosis (TB) Treatment Market Restraints
1.6.3 Tuberculosis (TB) Treatment Trends Analysis
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Tuberculosis (TB) Treatment Product and Solutions
2.1.4 Johnson & Johnson Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 Otsuka Pharmaceutical Co., Ltd
2.2.1 Otsuka Pharmaceutical Co., Ltd Details
2.2.2 Otsuka Pharmaceutical Co., Ltd Major Business
2.2.3 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Product and Solutions
2.2.4 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Otsuka Pharmaceutical Co., Ltd Recent Developments and Future Plans
2.3 Macleods Pharmaceutical Ltd
2.3.1 Macleods Pharmaceutical Ltd Details
2.3.2 Macleods Pharmaceutical Ltd Major Business
2.3.3 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Product and Solutions
2.3.4 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Macleods Pharmaceutical Ltd Recent Developments and Future Plans
2.4 Dong-A ST Co., Ltd
2.4.1 Dong-A ST Co., Ltd Details
2.4.2 Dong-A ST Co., Ltd Major Business
2.4.3 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Product and Solutions
2.4.4 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Dong-A ST Co., Ltd Recent Developments and Future Plans
2.5 Lupin Ltd
2.5.1 Lupin Ltd Details
2.5.2 Lupin Ltd Major Business
2.5.3 Lupin Ltd Tuberculosis (TB) Treatment Product and Solutions
2.5.4 Lupin Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Lupin Ltd Recent Developments and Future Plans
2.6 Janssen Products, LP
2.6.1 Janssen Products, LP Details
2.6.2 Janssen Products, LP Major Business
2.6.3 Janssen Products, LP Tuberculosis (TB) Treatment Product and Solutions
2.6.4 Janssen Products, LP Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Janssen Products, LP Recent Developments and Future Plans
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business
2.7.3 Mylan Tuberculosis (TB) Treatment Product and Solutions
2.7.4 Mylan Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Mylan Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Tuberculosis (TB) Treatment Product and Solutions
2.8.4 Sanofi Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Sanofi Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Tuberculosis (TB) Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Tuberculosis (TB) Treatment Players Market Share in 2021
3.2.2 Top 10 Tuberculosis (TB) Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Tuberculosis (TB) Treatment Players Head Office, Products and Services Provided
3.4 Tuberculosis (TB) Treatment Mergers & Acquisitions
3.5 Tuberculosis (TB) Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Tuberculosis (TB) Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Tuberculosis (TB) Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Tuberculosis (TB) Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Tuberculosis (TB) Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Tuberculosis (TB) Treatment Revenue by Type (2017-2028)
6.2 North America Tuberculosis (TB) Treatment Revenue by Application (2017-2028)
6.3 North America Tuberculosis (TB) Treatment Market Size by Country
6.3.1 North America Tuberculosis (TB) Treatment Revenue by Country (2017-2028)
6.3.2 United States Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Tuberculosis (TB) Treatment Revenue by Type (2017-2028)
7.2 Europe Tuberculosis (TB) Treatment Revenue by Application (2017-2028)
7.3 Europe Tuberculosis (TB) Treatment Market Size by Country
7.3.1 Europe Tuberculosis (TB) Treatment Revenue by Country (2017-2028)
7.3.2 Germany Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
7.3.3 France Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Tuberculosis (TB) Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Tuberculosis (TB) Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region
8.3.1 Asia-Pacific Tuberculosis (TB) Treatment Revenue by Region (2017-2028)
8.3.2 China Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
8.3.5 India Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Tuberculosis (TB) Treatment Revenue by Type (2017-2028)
9.2 South America Tuberculosis (TB) Treatment Revenue by Application (2017-2028)
9.3 South America Tuberculosis (TB) Treatment Market Size by Country
9.3.1 South America Tuberculosis (TB) Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Tuberculosis (TB) Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Tuberculosis (TB) Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country
10.3.1 Middle East & Africa Tuberculosis (TB) Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Tuberculosis (TB) Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Tuberculosis (TB) Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Tuberculosis (TB) Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Tuberculosis (TB) Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Tuberculosis (TB) Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Tuberculosis (TB) Treatment Revenue Market Share by Region (2023-2028)
Table 6. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 7. Johnson & Johnson Major Business
Table 8. Johnson & Johnson Tuberculosis (TB) Treatment Product and Solutions
Table 9. Johnson & Johnson Tuberculosis (TB) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Otsuka Pharmaceutical Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 11. Otsuka Pharmaceutical Co., Ltd Major Business
Table 12. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Product and Solutions
Table 13. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Macleods Pharmaceutical Ltd Corporate Information, Head Office, and Major Competitors
Table 15. Macleods Pharmaceutical Ltd Major Business
Table 16. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Product and Solutions
Table 17. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Dong-A ST Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 19. Dong-A ST Co., Ltd Major Business
Table 20. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Product and Solutions
Table 21. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Lupin Ltd Corporate Information, Head Office, and Major Competitors
Table 23. Lupin Ltd Major Business
Table 24. Lupin Ltd Tuberculosis (TB) Treatment Product and Solutions
Table 25. Lupin Ltd Tuberculosis (TB) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Janssen Products, LP Corporate Information, Head Office, and Major Competitors
Table 27. Janssen Products, LP Major Business
Table 28. Janssen Products, LP Tuberculosis (TB) Treatment Product and Solutions
Table 29. Janssen Products, LP Tuberculosis (TB) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Mylan Corporate Information, Head Office, and Major Competitors
Table 31. Mylan Major Business
Table 32. Mylan Tuberculosis (TB) Treatment Product and Solutions
Table 33. Mylan Tuberculosis (TB) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Sanofi Corporate Information, Head Office, and Major Competitors
Table 35. Sanofi Major Business
Table 36. Sanofi Tuberculosis (TB) Treatment Product and Solutions
Table 37. Sanofi Tuberculosis (TB) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Global Tuberculosis (TB) Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 39. Global Tuberculosis (TB) Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 40. Breakdown of Tuberculosis (TB) Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Tuberculosis (TB) Treatment Players Head Office, Products and Services Provided
Table 42. Tuberculosis (TB) Treatment Mergers & Acquisitions in the Past Five Years
Table 43. Tuberculosis (TB) Treatment New Entrants and Expansion Plans
Table 44. Global Tuberculosis (TB) Treatment Revenue (USD Million) by Type (2017-2022)
Table 45. Global Tuberculosis (TB) Treatment Revenue Share by Type (2017-2022)
Table 46. Global Tuberculosis (TB) Treatment Revenue Forecast by Type (2023-2028)
Table 47. Global Tuberculosis (TB) Treatment Revenue by Application (2017-2022)
Table 48. Global Tuberculosis (TB) Treatment Revenue Forecast by Application (2023-2028)
Table 49. North America Tuberculosis (TB) Treatment Revenue by Type (2017-2022) & (USD Million)
Table 50. North America Tuberculosis (TB) Treatment Revenue by Type (2023-2028) & (USD Million)
Table 51. North America Tuberculosis (TB) Treatment Revenue by Application (2017-2022) & (USD Million)
Table 52. North America Tuberculosis (TB) Treatment Revenue by Application (2023-2028) & (USD Million)
Table 53. North America Tuberculosis (TB) Treatment Revenue by Country (2017-2022) & (USD Million)
Table 54. North America Tuberculosis (TB) Treatment Revenue by Country (2023-2028) & (USD Million)
Table 55. Europe Tuberculosis (TB) Treatment Revenue by Type (2017-2022) & (USD Million)
Table 56. Europe Tuberculosis (TB) Treatment Revenue by Type (2023-2028) & (USD Million)
Table 57. Europe Tuberculosis (TB) Treatment Revenue by Application (2017-2022) & (USD Million)
Table 58. Europe Tuberculosis (TB) Treatment Revenue by Application (2023-2028) & (USD Million)
Table 59. Europe Tuberculosis (TB) Treatment Revenue by Country (2017-2022) & (USD Million)
Table 60. Europe Tuberculosis (TB) Treatment Revenue by Country (2023-2028) & (USD Million)
Table 61. Asia-Pacific Tuberculosis (TB) Treatment Revenue by Type (2017-2022) & (USD Million)
Table 62. Asia-Pacific Tuberculosis (TB) Treatment Revenue by Type (2023-2028) & (USD Million)
Table 63. Asia-Pacific Tuberculosis (TB) Treatment Revenue by Application (2017-2022) & (USD Million)
Table 64. Asia-Pacific Tuberculosis (TB) Treatment Revenue by Application (2023-2028) & (USD Million)
Table 65. Asia-Pacific Tuberculosis (TB) Treatment Revenue by Region (2017-2022) & (USD Million)
Table 66. Asia-Pacific Tuberculosis (TB) Treatment Revenue by Region (2023-2028) & (USD Million)
Table 67. South America Tuberculosis (TB) Treatment Revenue by Type (2017-2022) & (USD Million)
Table 68. South America Tuberculosis (TB) Treatment Revenue by Type (2023-2028) & (USD Million)
Table 69. South America Tuberculosis (TB) Treatment Revenue by Application (2017-2022) & (USD Million)
Table 70. South America Tuberculosis (TB) Treatment Revenue by Application (2023-2028) & (USD Million)
Table 71. South America Tuberculosis (TB) Treatment Revenue by Country (2017-2022) & (USD Million)
Table 72. South America Tuberculosis (TB) Treatment Revenue by Country (2023-2028) & (USD Million)
Table 73. Middle East & Africa Tuberculosis (TB) Treatment Revenue by Type (2017-2022) & (USD Million)
Table 74. Middle East & Africa Tuberculosis (TB) Treatment Revenue by Type (2023-2028) & (USD Million)
Table 75. Middle East & Africa Tuberculosis (TB) Treatment Revenue by Application (2017-2022) & (USD Million)
Table 76. Middle East & Africa Tuberculosis (TB) Treatment Revenue by Application (2023-2028) & (USD Million)
Table 77. Middle East & Africa Tuberculosis (TB) Treatment Revenue by Country (2017-2022) & (USD Million)
Table 78. Middle East & Africa Tuberculosis (TB) Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Tuberculosis (TB) Treatment Picture
Figure 2. Global Tuberculosis (TB) Treatment Revenue Market Share by Type in 2021
Figure 3. Isoniazid
Figure 4. Rifampin (Rifadin, Rimactane)
Figure 5. Ethambutol (Myambutol)
Figure 6. Pyrazinamide
Figure 7. Tuberculosis (TB) Treatment Revenue Market Share by Application in 2021
Figure 8. Active TB Picture
Figure 9. Latent TB Picture
Figure 10. Global Tuberculosis (TB) Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Tuberculosis (TB) Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Tuberculosis (TB) Treatment Revenue Market Share by Region (2017-2028)
Figure 13. Global Tuberculosis (TB) Treatment Revenue Market Share by Region in 2021
Figure 14. North America Tuberculosis (TB) Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Tuberculosis (TB) Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Tuberculosis (TB) Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Tuberculosis (TB) Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Tuberculosis (TB) Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Tuberculosis (TB) Treatment Market Drivers
Figure 20. Tuberculosis (TB) Treatment Market Restraints
Figure 21. Tuberculosis (TB) Treatment Market Trends
Figure 22. Johnson & Johnson Recent Developments and Future Plans
Figure 23. Otsuka Pharmaceutical Co., Ltd Recent Developments and Future Plans
Figure 24. Macleods Pharmaceutical Ltd Recent Developments and Future Plans
Figure 25. Dong-A ST Co., Ltd Recent Developments and Future Plans
Figure 26. Lupin Ltd Recent Developments and Future Plans
Figure 27. Janssen Products, LP Recent Developments and Future Plans
Figure 28. Mylan Recent Developments and Future Plans
Figure 29. Sanofi Recent Developments and Future Plans
Figure 30. Global Tuberculosis (TB) Treatment Revenue Share by Players in 2021
Figure 31. Tuberculosis (TB) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 32. Global Top 3 Players Tuberculosis (TB) Treatment Revenue Market Share in 2021
Figure 33. Global Top 10 Players Tuberculosis (TB) Treatment Revenue Market Share in 2021
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 35. Global Tuberculosis (TB) Treatment Revenue Share by Type in 2021
Figure 36. Global Tuberculosis (TB) Treatment Market Share Forecast by Type (2023-2028)
Figure 37. Global Tuberculosis (TB) Treatment Revenue Share by Application in 2021
Figure 38. Global Tuberculosis (TB) Treatment Market Share Forecast by Application (2023-2028)
Figure 39. North America Tuberculosis (TB) Treatment Sales Market Share by Type (2017-2028)
Figure 40. North America Tuberculosis (TB) Treatment Sales Market Share by Application (2017-2028)
Figure 41. North America Tuberculosis (TB) Treatment Revenue Market Share by Country (2017-2028)
Figure 42. United States Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Tuberculosis (TB) Treatment Sales Market Share by Type (2017-2028)
Figure 46. Europe Tuberculosis (TB) Treatment Sales Market Share by Application (2017-2028)
Figure 47. Europe Tuberculosis (TB) Treatment Revenue Market Share by Country (2017-2028)
Figure 48. Germany Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Tuberculosis (TB) Treatment Sales Market Share by Type (2017-2028)
Figure 54. Asia-Pacific Tuberculosis (TB) Treatment Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Tuberculosis (TB) Treatment Revenue Market Share by Region (2017-2028)
Figure 56. China Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South Korea Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Tuberculosis (TB) Treatment Sales Market Share by Type (2017-2028)
Figure 63. South America Tuberculosis (TB) Treatment Sales Market Share by Application (2017-2028)
Figure 64. South America Tuberculosis (TB) Treatment Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East and Africa Tuberculosis (TB) Treatment Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Tuberculosis (TB) Treatment Sales Market Share by Application (2017-2028)
Figure 69. Middle East and Africa Tuberculosis (TB) Treatment Revenue Market Share by Country (2017-2028)
Figure 70. Turkey Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. UAE Tuberculosis (TB) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
